Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hagberg

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
AIDS Research and Therapy|August 20, 2005
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionMagnus Gisslén, Lars Rosengren, Lars Hagberg, et al.
Scandinavian Journal of Infectious Diseases|March 15, 2005
Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimenAylin Yilmaz, Lars Ståhle, Lars Hagberg, et al.
Plos One|April 14, 2017
Physical Activity on Prescription (PAP), in patients with metabolic risk factors. A 6-month follow-up study in primary health careStefan Lundqvist, Mats Börjesson, Maria E H Larsson, et al.
Pharmacoeconomics - Open|January 9, 2025
Correction: Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population DataAnna Philipson, Lars Hagberg, Liselotte Hermansson, et al.
BMC Pediatrics|May 14, 2013
The effectiveness of proactive telephone support provided to breastfeeding mothers of preterm infants: study protocol for a randomized controlled trialJenny Ericson, Mats Eriksson, Lena Hellström-Westas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapyAylin Yilmaz, Richard W Price, Serena Spudich, et al.
Applied Health Economics and Health Policy|April 5, 2017
We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYsAnna Månsdotter, Björn Ekman, Inna Feldman, et al.
Pharmacoeconomics - Open|June 15, 2023
Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population DataAnna Philipson, Lars Hagberg, Liselotte Hermansson, et al.
Obesity Surgery|October 14, 2023
Levels of Physical Activity, Enjoyment, Self-Efficacy for Exercise, and Social Support Before and After Metabolic and Bariatric Surgery: a Longitudinal Prospective Observational StudyAnnika Imhagen, Jan Karlsson, Emma Ohlsson-Nevo, et al.
The Journal of Infectious Diseases|January 15, 2008
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapyArvid Edén, Richard W Price, Serena Spudich, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
AIDS Research and Therapy|August 20, 2005
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionMagnus Gisslén, Lars Rosengren, Lars Hagberg, et al.
Scandinavian Journal of Infectious Diseases|March 15, 2005
Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimenAylin Yilmaz, Lars Ståhle, Lars Hagberg, et al.
Plos One|April 14, 2017
Physical Activity on Prescription (PAP), in patients with metabolic risk factors. A 6-month follow-up study in primary health careStefan Lundqvist, Mats Börjesson, Maria E H Larsson, et al.
Pharmacoeconomics - Open|January 9, 2025
Correction: Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population DataAnna Philipson, Lars Hagberg, Liselotte Hermansson, et al.
BMC Pediatrics|May 14, 2013
The effectiveness of proactive telephone support provided to breastfeeding mothers of preterm infants: study protocol for a randomized controlled trialJenny Ericson, Mats Eriksson, Lena Hellström-Westas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapyAylin Yilmaz, Richard W Price, Serena Spudich, et al.
Applied Health Economics and Health Policy|April 5, 2017
We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYsAnna Månsdotter, Björn Ekman, Inna Feldman, et al.
Pharmacoeconomics - Open|June 15, 2023
Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population DataAnna Philipson, Lars Hagberg, Liselotte Hermansson, et al.
Obesity Surgery|October 14, 2023
Levels of Physical Activity, Enjoyment, Self-Efficacy for Exercise, and Social Support Before and After Metabolic and Bariatric Surgery: a Longitudinal Prospective Observational StudyAnnika Imhagen, Jan Karlsson, Emma Ohlsson-Nevo, et al.
The Journal of Infectious Diseases|January 15, 2008
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapyArvid Edén, Richard W Price, Serena Spudich, et al.
Pageof 14